Antibody Therapy with Rituximab for Patients with Low-Grade Non-Hodgkin’s Lymphoma

Publisher： Karger

E-ISSN： 2296-5262|22|3|184-190

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.22, Iss.3, 1999-07, pp. : 184-190

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Acute Toxicity of Mitoxantrone, Chlorambucil and Prednisolone (MCP) versus MCP plus Rituximab in Low-Grade Non-Hodgkin’s Lymphoma – Interim Results of a Phase III Trial

By  

Oncology Research and Treatment, Vol. 23, Iss. 2, 2000-05 ,pp. : 164-166

Karger

Access to resources Recommend Favorite

Is Bone Marrow Biopsy Obligatory in All Patients with Non-Hodgkin’s Lymphoma?

By  

Acta Haematologica, Vol. 118, Iss. 1, 2007-05 ,pp. : 61-64

Karger

Access to resources Recommend Favorite

Rituximab in Combination with Interferon-Alpha in Relapsed and Refractory Diffuse Large B-Cell Non-Hodgkin’s Lymphoma

By  

Acta Haematologica, Vol. 106, Iss. 3, 2001-11 ,pp. : 141-142

Karger

Access to resources Recommend Favorite

The Multicenter Trial SAKK 37/95 of Cladribine, Cyclophosphamide and Prednisone in the Treatment of Chronic Lymphocytic Leukemias and Low-Grade Non-Hodgkin’s Lymphomas

By  

Acta Haematologica, Vol. 117, Iss. 1, 2006-11 ,pp. : 40-47

Karger

Access to resources Recommend Favorite

Primary Non-Hodgkin’s Lymphoma of Urinary Bladder

By  

Urologia Internationalis, Vol. 72, Iss. 1, 2004-01 ,pp. : 82-84

Karger

Access to resources Recommend Favorite